Salmonella Hijacks an Immune Signal to Wipe Out Gut Bacteria, Mouse Study Finds

If a stomach bug has ever left someone you love fighting for their life in a hospital bed, the reason might not be the bacteria alone. A new mouse study in PLOS Biology points to an unexpected accomplice: the body's own immune response. Researchers found that a signaling protein called IL-1β, the same one recruited to help fight the infection, actually helps Salmonella win by destroying the protective bacteria that normally keep it contained. It's a finding that reframes a classic gut infection as a case of friendly fire, and it matters to anyone tracking how immune signaling and gut health intersect with disease risk.

Key Takeaways

• Mice without IL-1β cleared Salmonella almost 100-fold faster and every one of them survived, while all normal mice died from the same infection.
• IL-1β sends neutrophils (a type of infection-fighting white blood cell) flooding into the gut, and those cells destroy protective bacteria called Clostridia that would otherwise starve Salmonella out.
• The same pathway suppresses an enzyme called CPN1, unleashing a complement cascade that drives the kind of vascular damage seen in septic shock; blocking CPN1's target brought back 60% mortality even in otherwise-protected mice.
• This is a mouse study. In humans, the evidence is a correlation seen only in septic patients, not a treatment that has been tested.

IL-1β Drives Salmonella's Takeover of the Gut

IL-1β (interleukin-1 beta, an immune signaling protein released during infection to summon reinforcements) turns out to be one of the reasons Salmonella infections turn deadly, according to a study published in PLOS Biology. Researchers infected mice with Salmonella enterica serovar Typhimurium, a serovar that is a common cause of human foodborne illness, and compared normal mice to mice genetically engineered to lack IL-1β. The difference was stark: four days after infection, the IL-1β-deficient mice carried a 100-fold lower burden of Salmonella in the gut, and the bacteria were also reduced roughly 10-fold in the mesenteric lymph nodes, spleen, and liver, the organs Salmonella spreads to once it breaches the intestine. Every normal mouse died from the infection. Every IL-1β-deficient mouse survived. The result flips the usual assumption that more immune signaling means better protection, at least for this specific pathway.

Why Sepsis Risk and Gut Health Both Trace Back to This Pathway

This matters most directly to anyone thinking about sepsis, the body's out-of-control response to infection. Mayo Clinic describes it as an improper immune reaction that can send blood pressure crashing and starve organs of blood; septic shock carries a mortality rate of roughly 30% to 40%. Salmonella is not a rare threat either: the CDC estimates about 1.35 million Salmonella infections happen in the US every year, and it remains the leading cause of hospitalizations and deaths linked to foodborne illness. Most people clear a Salmonella infection without incident, but the mechanism this study describes, an immune signal that inadvertently clears the way for the pathogen and then triggers complement damage similar to septic shock, helps explain why a subset of infections turn severe. It is also relevant to anyone managing IBD, IBS, or another condition where gut inflammation and microbiome balance are already a daily concern, since the protective bacteria this study describes are the same short-chain-fatty-acid producers commonly discussed in gut health research generally.

Inside the Knockout-Mouse Experiment Behind the Finding

The researchers used a well-established infection model: C57BL/6 mice, some genetically normal and some engineered to lack the gene for IL-1β, were pretreated with the antibiotic streptomycin (a step that clears competing gut bacteria so Salmonella can establish itself, mimicking a disrupted microbiome) and then infected orally. A separate group was infected directly into the bloodstream to test whether the gut itself was essential to the effect. The team also ran co-housing experiments, letting normal and IL-1β-deficient mice share cages so their gut bacteria would normalize across groups, a way to rule out the possibility that the two groups simply started with different microbiomes. Within the gut, IL-1β-deficient mice had about four times fewer neutrophils infiltrating the colon, which meant less tissue damage and a gut environment that stayed inhospitable to Salmonella. The study was funded by the Azrieli Foundation, the Israel Science Foundation, the European Research Council Starting Grant program, and the US-Israel Binational Science Foundation, and the authors reported no competing interests.

What This Could Mean If You're Managing Your Own Gut Health

None of this changes how a Salmonella infection should be treated today, and the researchers did not test any drug or supplement in people. But the mechanism is worth understanding if you are the kind of reader who pays attention to how inflammation and gut bacteria interact. The protective actor in this story is a group of bacteria called Clostridia, which produce short-chain fatty acids that help keep the colon low in oxygen, an environment Salmonella struggles to grow in. When those bacteria are lost, whether from infection, antibiotics, or other disruption, the gut becomes more hospitable to opportunistic pathogens, a concept known as colonization resistance. That is consistent with a broader body of work on why a diverse, SCFA-producing microbiome matters, and it is a reasonable thing to raise with a doctor if you have a history of recurrent gut infections, unusually severe reactions to foodborne illness, or a condition that already involves gut inflammation. What it does not support is self-treating with any specific supplement or intervention; the study did not test one.

The Limits of a Single Mouse Study

The biggest caveat is the obvious one: this is a mouse study, and mice are not small humans. The human piece of the evidence is a correlation, not a causal test. Researchers found that IL-1β expression tracked with expression of a complement receptor gene called C3AR1 in septic patients, but not in healthy people, which is suggestive but not proof that the same pathway drives human sepsis the way it drives mouse death. The study also has not yet been independently replicated by another lab, which matters for a mechanism this specific. And while the team closed the causal loop by showing that blocking CPN1's downstream target restored deadly outcomes in otherwise-protected mice, that experiment happened in mice too. Nobody has tested a CPN1-targeted or complement-targeted drug in Salmonella-infected people.

What Comes Next for Testing the Complement Pathway

The logical next step is testing whether the same pathway, IL-1β driving neutrophil damage and complement dysregulation, plays out the same way in human sepsis and severe Salmonella infections, ideally with a prospective study rather than a retrospective correlation. If it holds up, the complement enzyme CPN1 becomes a plausible drug target for limiting the vascular damage that makes sepsis so dangerous, separate from antibiotics aimed at killing the bacteria itself. That kind of translational work, from mouse mechanism to human trial, typically takes years, and there is no announced timeline for a human study in this paper.

Common Questions

Does this mean IL-1β is always bad during infection? No. The study only shows this specific pathway backfires during Salmonella infection in mice; IL-1β plays protective roles against other pathogens, and blocking it broadly is not something the study tested or recommends.

Should someone avoid anti-inflammatory drugs during a Salmonella infection? The study did not test any drug in people, so it does not answer that question; anyone with a suspected Salmonella infection should follow their doctor's guidance rather than self-adjust medication based on a mouse study.

What are Clostridia and why do they matter here? Clostridia are a group of gut bacteria that produce short-chain fatty acids, compounds that help keep the colon low in oxygen and make it harder for Salmonella and similar pathogens to grow; the study found IL-1β indirectly wipes these bacteria out.

References

1. Mor Zigdon, Jasmin Sawaed, Lilach Zelik, et al. (2024). Salmonella manipulates the host to drive pathogenicity via induction of interleukin 1β. PLOS Biology. https://doi.org/10.1371/journal.pbio.3002486
2. About Salmonella Infection | CDC. cdc.gov. https://www.cdc.gov/salmonella/about/index.html